Results 151 to 160 of about 16,301 (208)

Lycopene Ameliorates Metabolic Dysfunction-Associated Steatotic Liver Disease via PINK1/Parkin-Mediated Mitophagy Activation and Apoptosis Attenuation. [PDF]

Antioxidants (Basel)
Xu Z, Wu X, Ye L, Li Z, Zhao J, Zhang Z, Sun Y.   +6 more
europepmc   +1 more source

GPIHBP1 Autoantibody-Related Hypertriglyceridemia in a 12-Year-Old Girl With Systemic Lupus Erythematosus. [PDF]

Case Rep Endocrinol
Lai ST, Chan SS, Yu SCY, Cheng JYK, Tsui KT, Ho CA, Yau HC.   +6 more
europepmc   +1 more source

Review Article: Targeting Peroxisome Proliferator-Activated Receptors in Primary Biliary Cholangitis. [PDF]

Aliment Pharmacol Ther
Schattenberg JM, Banales JM, Hirschfield G, Trivedi P, Cable EE, McWherter CA, Billin AN, Crittenden DB, Budas G.   +8 more
europepmc   +1 more source

2025: The year in cardiovascular disease - the year of triglyceride lowering therapies. Can we effectively reduce triglyceride-related residual cardiovascular disease and pancreatitis risk? [PDF]

Arch Med Sci
Toth PP, Banach M, International Lipid Expert Panel (ILEP).   +2 more
europepmc   +1 more source

Current perspectives on lipid management in diabetic kidney disease: Can fibrates offer advantages over statins for renal outcomes? [PDF]

J Res Med Sci
Chitsazi MR, Safari F, Malekpour E, Mirzaei SA, Shafieyoun MH, Golafshan F, Rouzbahani H, Nekookhoo M, Noursina A, Siavash M.   +9 more
europepmc   +1 more source

Deletion of <i>Bmal1</i>, a Component of the Molecular Clock, Exacerbates Kidney Damage After Ischemia-Reperfusion by Decreasing <i>Pparα</i> Expression. [PDF]

Int J Mol Sci
Kitaura S, Wada T, Asano Y, Shimba S.
europepmc   +1 more source

Development and evaluation of an effective solubility prediction model for pharmaceuticals in organic solvents using machine learning based on eXtreme Gradient Boosting. [PDF]

Sci Rep
Valavi M, Assareh M, Khoshsima A, Svärd M.   +3 more
europepmc   +1 more source

Fenofibrate therapy and risk of heart failure outcomes in patients with Type 2 diabetes: a propensity-matched cohort study. [PDF]

Eur Heart J Cardiovasc Pharmacother
Kim JY, Kim NH, Lee J, Kim DH, Kim SG.
europepmc   +1 more source

Long-acting fenofibrate-loaded microparticles for treating retinal disorders. [PDF]

Int J Pharm
Poudel S, Cui Y, Meng T, Liang W, Zhou K, Cheng R, Zhao L, Yuan T, Kaffash E, Halquist MS, Ma JX, Xu Q.   +11 more
europepmc   +1 more source